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Luca Cioccari1, Bjoern Zante1, Andreas Bloch1, David Berger1, Andreas Limacher2, Stephan M. Jakob1,
Jukka Takala1 and Tobias M. Merz1*Correction
Following publication of the original article [1], the au-
thors reported an error in the sample size calculation.
This correction presents the incorrect, as well as the
correct sample size declaration.
Incorrect text:
– “Sample size calculation is based on a
retrospective analysis of a sample of 159 patients
admitted to our ICU during a 3-month period,
which fulfilled the study entry criteria. Median
time to resolution of circulatory shock, defined as
mean systemic blood pressure > 60 mmHg and
resolution of clinical signs of shock (capillary
refilling time < 3 s, urine output > 0.5 mL/kg/h
for at least 4 h, blood lactate < 2 mmol/L), in this
sample was 18.5 h (Fig. 1).”
Correct text:
– “Sample size calculation is based on a retrospective
analysis of a sample of 159 patients admitted to our
ICU during a 3-month period, which fulfilled the
study entry criteria. Median time to resolution of
hemodynamic instability as defined by discontinu-
ation of vasopressors or inotropes in this sample was
18.5 hours (Fig. 1).”* Correspondence: tobias.merz@insel.ch
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© The Author(s). 2018 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeThe corrected text is identical to the previously pub-
lished text in the statistical analysis plan on clinicaltrials.-
gov (https://clinicaltrials.gov/ProvidedDocs/66/NCT020
48566/SAP_000.pdf<https://urldefense.proofpoint.com/
v2/url?u=https-3A__clinicaltrials.gov_ProvidedDocs_66_
NCT02048566_SAP-5F000.pdf&d=DwMFAg&c=vh6Fg
FnduejNhPPD0fl_yRaSfZy8CWbWnIf4XJhSqx8&r=_
Sjd0yL0bevGob014KdftSO3mW49mj-Kr7McyIsCy_Y&
m=AeaiTL7BjsfUmXrb_dSMaLQ5Kx9w-0qwysAG5x2S
jG0&s=FLSBCcMk0RdwkyPG5QQdZEewtqwDLO1Zt8Iu
MreqQ4o&e).
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